As per Intent Market Research, the Clinical Laboratory Tests Market was valued at USD 120.1 Billion in 2024-e and will surpass USD 211.2 Billion by 2030; growing at a CAGR of 9.9% during 2025-2030.
The clinical laboratory tests market plays a critical role in the healthcare industry, providing essential diagnostic services that aid in disease detection, treatment monitoring, and health assessment. The market is driven by rising healthcare awareness, an increasing prevalence of chronic diseases, and advancements in diagnostic technologies. The growing adoption of automation and artificial intelligence in laboratory processes is further enhancing test accuracy and efficiency.
Different types of clinical tests serve various medical purposes, ranging from routine screenings to specialized disease monitoring. The demand for these tests is expanding due to factors such as an aging population, higher disease burden, and the shift toward preventive healthcare. Moreover, the rising adoption of home-based testing and telemedicine is reshaping the industry landscape, offering convenience and accessibility.
Complete Blood Count (CBC) Segment is Largest Owing to Its Broad Diagnostic Applications
Complete Blood Count (CBC) is the most commonly performed laboratory test due to its essential role in diagnosing infections, anemia, leukemia, and other hematological disorders. CBC tests are often included in routine health screenings, preoperative evaluations, and disease monitoring. The test's ability to provide a quick and comprehensive overview of a patient’s overall health has led to its widespread adoption across healthcare settings.
The increasing prevalence of chronic diseases such as cancer and autoimmune disorders has further propelled the demand for CBC tests. Additionally, technological advancements, such as automated hematology analyzers, have improved test accuracy and efficiency. With rising health consciousness and increased preventive care initiatives, the CBC segment is expected to maintain its dominance in the clinical laboratory tests market.
.JPG)
Disease Diagnosis Segment is Largest Due to Growing Prevalence of Chronic Conditions
The disease diagnosis segment accounts for the largest share in the clinical laboratory tests market, driven by the increasing burden of chronic diseases such as diabetes, cardiovascular disorders, and infectious diseases. Diagnostic tests are essential for early disease detection, which is crucial for effective treatment and improved patient outcomes. The growing awareness of disease prevention and management has led to a surge in diagnostic test utilization.
The COVID-19 pandemic further accelerated the adoption of diagnostic testing, increasing investments in laboratory infrastructure and boosting the demand for advanced testing technologies. Additionally, the rising prevalence of lifestyle-related disorders and the growing geriatric population are fueling market expansion. As healthcare providers emphasize early diagnosis and personalized treatment approaches, the disease diagnosis segment will continue to dominate the market.
Diagnostic Laboratories Segment is Largest Due to High Test Volume and Advanced Infrastructure
Diagnostic laboratories hold the largest market share due to their ability to process high test volumes efficiently. These laboratories are equipped with advanced diagnostic equipment, automated analyzers, and AI-driven solutions, ensuring rapid and accurate test results. The growing outsourcing of diagnostic services by hospitals and clinics has further strengthened the role of diagnostic laboratories in the market.
The increasing demand for specialized testing, such as molecular diagnostics and genetic testing, has led to continuous technological advancements in diagnostic laboratories. Additionally, the expansion of laboratory networks and strategic collaborations between healthcare providers and lab service providers are driving market growth. The rise of direct-to-consumer lab testing options is also expanding the reach of diagnostic laboratories globally.
Asia-Pacific Region is Fastest Growing Due to Expanding Healthcare Infrastructure and Rising Disease Burden
The Asia-Pacific region is witnessing the fastest growth in the clinical laboratory tests market, driven by rapid urbanization, increasing healthcare expenditure, and a growing middle-class population with higher health awareness. Countries like China, India, and Japan are leading the expansion due to their large patient populations and government initiatives to improve healthcare access.
The rising prevalence of infectious diseases, diabetes, and cardiovascular conditions in Asia-Pacific has significantly increased the demand for diagnostic testing. Additionally, the adoption of advanced laboratory automation, telehealth services, and mobile health diagnostics is further fueling market growth. Investments in healthcare infrastructure and the expansion of private diagnostic labs are expected to drive continued market expansion in the region.
.JPG)
Competitive Landscape and Key Market Players
The clinical laboratory tests market is highly competitive, with major global players focusing on technological advancements, strategic acquisitions, and service expansion to strengthen their market position. Leading companies such as LabCorp, Quest Diagnostics, Sonic Healthcare, Eurofins Scientific, and Mayo Clinic Laboratories dominate the industry, leveraging their extensive laboratory networks and advanced diagnostic capabilities.
The market is also witnessing increased partnerships between healthcare providers and diagnostic service providers to enhance test accessibility and affordability. Additionally, the rise of home-based testing solutions and AI-powered diagnostic tools is reshaping competition dynamics. Companies that invest in automation, digital health solutions, and innovative diagnostic technologies are expected to gain a competitive edge in the evolving market landscape.
List of Leading Companies:
- Laboratory Corporation of America Holdings (LabCorp)
- Quest Diagnostics Incorporated
- Sonic Healthcare Limited
- Eurofins Scientific
- BioReference Laboratories
- Charles River Laboratories
- ARUP Laboratories
- Abbott Laboratories
- Siemens Healthineers
- Mayo Clinic Laboratories
- OPKO Health
- Genomic Health (Exact Sciences)
- NeoGenomics Laboratories
- Unilabs
- KingMed Diagnostics
Recent Developments:
- In 2024, LabCorp introduced a new range of home-based diagnostic tests for chronic disease monitoring.
- Quest Diagnostics acquired a leading European pathology laboratory in 2023 to strengthen its global footprint.
- Siemens introduced an AI-powered clinical lab automation system in 2024 to improve testing accuracy and efficiency.
- Eurofins Scientific Partners with Pharma Company – In 2023, Eurofins announced a strategic collaboration with a pharmaceutical firm to enhance its specialized diagnostic services.
- Mayo Clinic Laboratories launched an advanced genetic screening service in 2024, focusing on early disease detection.
Report Scope:
|
Report Features |
Description |
|
Market Size (2024-e) |
USD XX billion |
|
Forecasted Value (2030) |
USD XX billion |
|
CAGR (2025 – 2030) |
XX% |
|
Base Year for Estimation |
2024-e |
|
Historic Year |
2023 |
|
Forecast Period |
2025 – 2030 |
|
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
|
Segments Covered |
Clinical Laboratory Tests Market By Test Type (Complete Blood Count (CBC), Basic Metabolic Panel (BMP), Comprehensive Metabolic Panel (CMP), Lipid Panel, Liver Panel, Renal Panel, Hemoglobin A1C Test, Thyroid Function Test, Coagulation Tests, Infectious Disease Testing), By Application (Routine Health Checkups, Disease Diagnosis, Monitoring of Chronic Conditions, Preoperative Testing, Drug Testing), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutions, Home-Based Testing, Specialty Laboratories) |
|
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
|
Major Companies |
Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Sonic Healthcare Limited, Eurofins Scientific, BioReference Laboratories, Charles River Laboratories, ARUP Laboratories, Abbott Laboratories, Siemens Healthineers, Mayo Clinic Laboratories, OPKO Health, Genomic Health (Exact Sciences), NeoGenomics Laboratories, Unilabs, KingMed Diagnostics |
|
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
Frequently Asked Questions
The Clinical Laboratory Tests Market was valued at USD 120.1 Billion in 2024-e and is expected to grow at a CAGR of over 9.9% from 2025 to 2030
North America dominates due to its well-established healthcare infrastructure, high healthcare spending, and early adoption of advanced diagnostic technologies.
Automation improves efficiency, reduces human errors, and enhances the speed and accuracy of test results, driving growth in diagnostic laboratories.
Challenges include regulatory compliance, high costs of advanced diagnostic technologies, and reimbursement issues in developing markets.
|
1. Introduction |
|
1.1. Market Definition |
|
1.2. Scope of the Study |
|
1.3. Research Assumptions |
|
1.4. Study Limitations |
|
2. Research Methodology |
|
2.1. Research Approach |
|
2.1.1. Top-Down Method |
|
2.1.2. Bottom-Up Method |
|
2.1.3. Factor Impact Analysis |
|
2.2. Insights & Data Collection Process |
|
2.2.1. Secondary Research |
|
2.2.2. Primary Research |
|
2.3. Data Mining Process |
|
2.3.1. Data Analysis |
|
2.3.2. Data Validation and Revalidation |
|
2.3.3. Data Triangulation |
|
3. Executive Summary |
|
3.1. Major Markets & Segments |
|
3.2. Highest Growing Regions and Respective Countries |
|
3.3. Impact of Growth Drivers & Inhibitors |
|
3.4. Regulatory Overview by Country |
|
4. Clinical Laboratory Tests Market, by Test Type (Market Size & Forecast: USD Million, 2023 – 2030) |
|
4.1. Complete Blood Count (CBC) |
|
4.2. Basic Metabolic Panel (BMP) |
|
4.3. Comprehensive Metabolic Panel (CMP) |
|
4.4. Lipid Panel |
|
4.5. Liver Panel |
|
4.6. Renal Panel |
|
4.7. Hemoglobin A1C Test |
|
4.8. Thyroid Function Test |
|
4.9. Coagulation Tests |
|
4.10. Infectious Disease Testing |
|
5. Clinical Laboratory Tests Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030) |
|
5.1. Routine Health Checkups |
|
5.2. Disease Diagnosis |
|
5.3. Monitoring of Chronic Conditions |
|
5.4. Preoperative Testing |
|
5.5. Drug Testing |
|
6. Clinical Laboratory Tests Market, by End-User (Market Size & Forecast: USD Million, 2023 – 2030) |
|
6.1. Hospitals & Clinics |
|
6.2. Diagnostic Laboratories |
|
6.3. Research & Academic Institutions |
|
6.4. Home-Based Testing |
|
6.5. Specialty Laboratories |
|
7. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030) |
|
7.1. Regional Overview |
|
7.2. North America |
|
7.2.1. Regional Trends & Growth Drivers |
|
7.2.2. Barriers & Challenges |
|
7.2.3. Opportunities |
|
7.2.4. Factor Impact Analysis |
|
7.2.5. Technology Trends |
|
7.2.6. North America Clinical Laboratory Tests Market, by Test Type |
|
7.2.7. North America Clinical Laboratory Tests Market, by Application |
|
7.2.8. North America Clinical Laboratory Tests Market, by End-User |
|
7.2.9. By Country |
|
7.2.9.1. US |
|
7.2.9.1.1. US Clinical Laboratory Tests Market, by Test Type |
|
7.2.9.1.2. US Clinical Laboratory Tests Market, by Application |
|
7.2.9.1.3. US Clinical Laboratory Tests Market, by End-User |
|
7.2.9.2. Canada |
|
7.2.9.3. Mexico |
|
*Similar segmentation will be provided for each region and country |
|
7.3. Europe |
|
7.4. Asia-Pacific |
|
7.5. Latin America |
|
7.6. Middle East & Africa |
|
8. Competitive Landscape |
|
8.1. Overview of the Key Players |
|
8.2. Competitive Ecosystem |
|
8.2.1. Level of Fragmentation |
|
8.2.2. Market Consolidation |
|
8.2.3. Product Innovation |
|
8.3. Company Share Analysis |
|
8.4. Company Benchmarking Matrix |
|
8.4.1. Strategic Overview |
|
8.4.2. Product Innovations |
|
8.5. Start-up Ecosystem |
|
8.6. Strategic Competitive Insights/ Customer Imperatives |
|
8.7. ESG Matrix/ Sustainability Matrix |
|
8.8. Manufacturing Network |
|
8.8.1. Locations |
|
8.8.2. Supply Chain and Logistics |
|
8.8.3. Product Flexibility/Customization |
|
8.8.4. Digital Transformation and Connectivity |
|
8.8.5. Environmental and Regulatory Compliance |
|
8.9. Technology Readiness Level Matrix |
|
8.10. Technology Maturity Curve |
|
8.11. Buying Criteria |
|
9. Company Profiles |
|
9.1. Laboratory Corporation of America Holdings (LabCorp) |
|
9.1.1. Company Overview |
|
9.1.2. Company Financials |
|
9.1.3. Product/Service Portfolio |
|
9.1.4. Recent Developments |
|
9.1.5. IMR Analysis |
|
*Similar information will be provided for other companies |
|
9.2. Quest Diagnostics Incorporated |
|
9.3. Sonic Healthcare Limited |
|
9.4. Eurofins Scientific |
|
9.5. BioReference Laboratories |
|
9.6. Charles River Laboratories |
|
9.7. ARUP Laboratories |
|
9.8. Abbott Laboratories |
|
9.9. Siemens Healthineers |
|
9.10. Mayo Clinic Laboratories |
|
9.11. OPKO Health |
|
9.12. Genomic Health (Exact Sciences) |
|
9.13. NeoGenomics Laboratories |
|
9.14. Unilabs |
|
9.15. KingMed Diagnostics |
|
10. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Clinical Laboratory Tests Market . In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Clinical Laboratory Tests Market . The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
.jpg)
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Clinical Laboratory Tests Market . These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
.jpg)
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.